3-aminobenzamide has been researched along with Ovarian Neoplasms in 9 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, J | 2 |
| Kan, Y | 1 |
| Tian, Y | 1 |
| Wang, Z | 1 |
| Beauchamp, MC | 1 |
| Knafo, A | 1 |
| Yasmeen, A | 1 |
| Carboni, JM | 1 |
| Gottardis, MM | 1 |
| Pollak, MN | 1 |
| Gotlieb, WH | 1 |
| Nguewa, PA | 1 |
| Fuertes, MA | 1 |
| Cepeda, V | 1 |
| Alonso, C | 1 |
| Quevedo, C | 1 |
| Soto, M | 1 |
| Pérez, JM | 1 |
| Bürkle, A | 1 |
| Chen, G | 4 |
| Küpper, JH | 1 |
| Grube, K | 1 |
| Zeller, WJ | 4 |
| Boike, GM | 1 |
| Petru, E | 1 |
| Sevin, BU | 1 |
| Averette, HE | 1 |
| Chou, TC | 1 |
| Penalver, M | 1 |
| Donato, D | 1 |
| Schiano, M | 1 |
| Hilsenbeck, SG | 1 |
| Perras, J | 1 |
| He, YJ | 1 |
| Liu, RH | 1 |
| Ning, CQ | 1 |
| Yu, NF | 1 |
1 review available for 3-aminobenzamide and Ovarian Neoplasms
| Article | Year |
|---|---|
[Research progresses of the PARP inhibitors for the treatment of cancer].
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; DNA Repair; Drug Therapy, Combinat | 2013 |
8 other studies available for 3-aminobenzamide and Ovarian Neoplasms
| Article | Year |
|---|---|
Effects of poly (ADP-ribosyl) polymerase (PARP) inhibitor on cisplatin resistance & proliferation of the ovarian cancer C13* cells.
Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; E | 2013 |
BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzimidazoles; Cell Line, Tumor; DNA Da | 2009 |
Poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide enhances apoptosis induction by platinum complexes in cisplatin-resistant tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cisplatin; Drug Resistance, Neoplasm; Drug Sy | 2006 |
Increased poly(ADP-ribosyl)ation in intact cells by cisplatin treatment.
Topics: Animals; Benzamides; Cisplatin; DNA Repair; DNA, Neoplasm; Enzyme Induction; Female; Fluorescent Ant | 1993 |
Multiple effects of 3-aminobenzamide on DNA damage induced by cisplatin (DDP) in DDP-sensitive and -resistant rat ovarian tumor cell lines.
Topics: Animals; Benzamides; Cisplatin; DNA; DNA Damage; Drug Resistance; Female; Ovarian Neoplasms; Poly(AD | 1992 |
Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line.
Topics: Adenosine Triphosphate; Benzamides; Caffeine; Cells, Cultured; Cisplatin; Dose-Response Relationship | 1990 |
In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line.
Topics: Animals; Antimetabolites; Benzamides; Buthionine Sulfoximine; Cell Line; Cisplatin; DNA; Drug Resist | 1990 |
Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cisplatin; Drug Resistance; Dru | 1990 |